An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Depression
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of SR58611A in elderly
patients with depression.The primary objective is to evaluate the efficacy of a 700 mg dose
of SR58611A compared to placebo in elderly patients with depression. The secondary objectives
are to evaluate the safety of SR58611A and to evaluate the efficacy of SR58611A on disability
and quality of life in elderly patients with depression.